Skip to main content

Day: August 27, 2020

Independence Gold Announces Exploration at Spences Bridge Projects

VANCOUVER, British Columbia, Aug. 27, 2020 (GLOBE NEWSWIRE) — Independence Gold Corp. (TSX.V: IGO) (“Independence” or “the Company”) is pleased to announce that exploration work has commenced on the Merit and Nicoamen properties, located in the Spences Bridge Gold Belt, British Columbia. Exploration work will consist of geological mapping, prospecting, and surface sampling.Both projects were explored in 2019 and several new gold and silver targets were defined during the field exploration program primarily focused on low-sulphide epithermal quartz vein systems, although several other targets of mineralization have been found within younger intrusive bodies. The 2020 program will further delineate and extend the strike length of these target zones and define future drill exploration programs. Drill permits...

Continue reading

Guardion Health Sciences Product Licensee Receives Registration Approval in Malaysia for Immune Support Supplement

SAN DIEGO, Aug. 27, 2020 (GLOBE NEWSWIRE) — Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) today announced that Ho Wah Genting Berhad (“HWGB”), a Malaysian company listed on the Malaysian Stock Exchange (KLSE:9601), has received product registration approval for Astramern Nutra V, an immune support dietary supplement designed and produced by Guardion. The approval of Astramern Nutra V by the Malaysian National Pharmaceutical Regulatory Agency (“NPRA”), which is effective through August 21, 2025, represents an important step in HWGB’s efforts to market and distribute Astramern Nutra V in Malaysia.In early 2020, HWGB entered into a Manufacturing and Supply Agreement with Guardion for Guardion to design and manufacture two immune support dietary supplements, Astramern Nutra V, a vitamin formulation, and...

Continue reading

EMCORE Corporation to Participate in the Jefferies Virtual Semiconductor, IT Hardware & Communications Infrastructure Summit

ALHAMBRA, Calif., Aug. 27, 2020 (GLOBE NEWSWIRE) — EMCORE Corporation (NASDAQ: EMKR), a leading provider of advanced mixed-signal products that serve the aerospace & defense and broadband communications markets, today announced management will participate in the Jefferies Virtual Semiconductor, IT Hardware & Communications Infrastructure Summit on Tuesday, September 1, 2020.About EMCOREEMCORE Corporation is a leading provider of advanced mixed-signal products that serve the aerospace & defense and broadband communications markets. Our best-in-class components and systems support a broad array of applications including navigation and inertial sensing, defense optoelectronics, broadband transport, 5G wireless infrastructure, optical sensing, and cloud data centers. We leverage industry-leading Quartz MEMS, Lithium Niobate...

Continue reading

ARHT Media Announces Q2 2020 Financial Results

Fiscal and Operational Changes reduce Q2 losses by 52% versus Q2 2019Q3 Revenue on Track to More than Double Year over YearCurrent Cash Position Is $1,700k versus $386k at the Beginning of Q2Second Quarter and Post Quarter 2020 Highlights:Q2 revenues of $42k vs $566k YoY, decrease of 93%Q2 loss of $533k vs $1,113k YoY, decrease of 52%Company focus on Channel Reseller and Strategic Partnerships to accelerate revenue growthCompany signs ALMO Pro AV as exclusive US Reseller – 32 major markets to have ARHT technologyHighly anticipated HoloPod Display successfully tested with move to production units in Q3Initial activations of enhanced online presentation, Virtual Global Stage™ (VGS), universally praisedOrganizations forced to use technology to communicate with employees and clients positioning ARHT Media as an enhanced platform either online...

Continue reading

Almenna leigufélagið ehf.: Árshlutareikningur fyrri árshelmings 2019

Á fundi sínum í dag samþykkti stjórn Almenna leigufélagsins ehf. árshlutareikning samstæðunnar fyrir fyrri árshelming 2020Rekstrartekjur samstæðunnar voru 1.335 m.kr. á tímabilinu. Þá var EBITDA (rekstrarhagnaður fyrir matsbreytingu, afskriftir og fjármagnsliði) 748 m.kr. fyrir tímabilið. Tap varð af rekstri samstæðunnar á tímabilinu að fjárhæð 281 m.kr., þar af er neikvæð matsbreyting að fjárhæð 424 m.kr. sem má að mestu leyti rekja til breytinga í skammtímahorfum í rekstri hótelíbúða samstæðunnar. Handbært fé frá rekstri nam 317 m.kr. og jókst um 182 m.kr. frá fyrra ári.  Heildareignir samstæðunnar námu 46.611 m.kr. 30. júní 2020, en þar af voru fjárfestingareignir 43.892 m.kr. og handbært fé var 1.564 m.kr. Vaxtaberandi skuldir námu 29.470 m.kr. og eigið fé samstæðunnar var 12.421 m.kr.María Björk Einarsdóttir, framkvæmdastjóri Almenna...

Continue reading

CHF Solutions Applauds U.S Congress Request to U.S. International Trade Commission to Identify Products to Treat COVID-19

EDEN PRAIRIE, Minn., Aug. 27, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today commended a request from the U.S. Congress to the U.S. International Trade Commission (USITC) concerning the availability of U.S.-sourced medical supplies to treat COVID-19 and future pandemics.Following up on prior USITC reports, the House Committee on Ways and Means and Senate Committee jointly issued a formal request on August 13, 2020, calling on USITC to conduct a follow-on investigation and prepare a report to Congress, which is expected to aid Congress in making “critical policymaking decisions” concerning U.S. COVID-related industry sectors, including the medical device industry.“CHF Solutions is grateful for Congress’ important efforts...

Continue reading

Árshlutauppgör Landsbréfa 30. júní 2020

Landsbréf hf. hafa birt árshlutareikning fyrir fyrri hluta ársins 2020.  Helstu niðurstöður voru þessar:Hagnaður af rekstri Landsbréfa nam á fyrri hluta ársins 232 milljónum króna samanborið við 301 milljón króna fyrir sama tímabil árið áður.  Hreinar rekstrartekjur námu 844 milljónum króna á fyrri hluta ársins 2020 samanborið við 921 milljón króna fyrir sama tímabil árið áður.Eigið fé í lok tímabils var 4.523 milljónir króna samanborið við 4.291 milljónir króna í árslok 2019. Eiginfjárhlutfall Landsbréfa er 93,89% við lok tímabilsins.Alls voru um 14 þúsund viðskiptavinir með fjármuni í sjóðum Landsbréfa og voru eignir í stýringu um 186 milljarðar króna í lok tímabils samanborið við 180 milljarða króna í upphafi árs.Helgi Þór Arason, framkvæmdastjóri Landsbréfa:„Árið 2020 hefur að mörgu leyti verið óvenjulegt ár, þar sem heimsfaraldur...

Continue reading

Waturu Holding A/S – Half-year report 2020

Company announcement no. 36Vejle, August 27th 2020Half-year report 2020“The Board of Directors of Waturu Holding A/S has today approved the half-year report for the first half-year of 2020”The half-year report has been audited by Beierholm Revision.Highlights from the first half-year 2020:1. The result is considered satisfactory, considering that the launch of products in the first half of 2020 was delayed. A lot of work has gone into trying to shorten the delay.2. The balance sheet of the accounts now includes the valuation of Waturu Holdings’ ownership of the subsidiary Watgen Medical A/S, which is recognized with 50,3 MDKK in equity.3. Costs have been incurred for the purchase of sub-components and investments have been made in marketing activities for the launch of Waturu´s decentralized high-efficiency water heater.4....

Continue reading

Waturu Holding A/S – halvårsrapport 1. halvår 2020

Selskabsmeddelelse nr. 36Vejle, 27. august 2020Halvårsrapport, 1. halvår 2020Bestyrelsen for Waturu Holding A/S har i dag godkendt halvårsrapporten for første halvår 2020.Halvårsrapporten er Revideret af Beierholm Revision.3. Der er afholdt omkostninger til indkøb af delkomponenter samt gennemført investeringer i markedsføringsaktiviteter til lancering af Waturu´s decentrale højeffektive vandvarmer.5. Der er afholdt udviklings- og testomkostninger til OEM-produkter indenfor VVS, spildevand samt medico branchen.På trods af den nuværende situation, hvor markederne endnu er påvirket af Covid-19, er bestyrelsen i Waturu Holding A/S tilfreds med udviklingen samt de fremadrettede forretningsmuligheder.Bestyrelsen fastholder de udmeldte langsigtede forventninger, som er opdateret i selskabsmeddelelse nr. 28, der opjusterer de overordnede omsætningsmål...

Continue reading

TRACON Pharmaceuticals Announces $5.0 Million Private Placement

SAN DIEGO, Aug. 27, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced that it has entered into a definitive securities purchase agreement with an institutional health care focused fund to raise aggregate gross proceeds of approximately $5.0 million through a private placement of its common stock and pre-funded warrants. The closing of the private placement is expected to occur on or about August 27, 2020.TRACON will sell approximately 3.1 million shares of common stock, or in lieu of common stock, pre-funded...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.